AXB
60.3
+0.84%↑
JPM
294.13
+1.77%↑
BAC
45.83
+0.48%↑
WFC
77.54
-0.32%↓
MS
141.35
+1.6%↑
AXB
60.3
+0.84%↑
JPM
294.13
+1.77%↑
BAC
45.83
+0.48%↑
WFC
77.54
-0.32%↓
MS
141.35
+1.6%↑
AXB
60.3
+0.84%↑
JPM
294.13
+1.77%↑
BAC
45.83
+0.48%↑
WFC
77.54
-0.32%↓
MS
141.35
+1.6%↑
AXB
60.3
+0.84%↑
JPM
294.13
+1.77%↑
BAC
45.83
+0.48%↑
WFC
77.54
-0.32%↓
MS
141.35
+1.6%↑
AXB
60.3
+0.84%↑
JPM
294.13
+1.77%↑
BAC
45.83
+0.48%↑
WFC
77.54
-0.32%↓
MS
141.35
+1.6%↑
24h
Current
Min
5.6
Max
5.83
Income | 331M |
---|---|
Sales | 75M 1.6B |
P/E Sector Avg | 2.787 25.916 |
EPS | 2.85 |
Dividend yield | 6.98 |
Profit margin | 21.321 |
Employees | 949 |
EBITDA | -32M 307M |
Dividend yield Sector Avg | 6.98% 3.70% |
---|---|
Next Earnings | 19 Aug 2025 |
Market Cap | -48M 520M |
---|---|
Previous open | 2.4 |
Previous close | 5.79 |
By Trading Central
Confidence
Bearish Evidence
6.2 / 6.45 Support & Resistance
Past performance is not a reliable indicator of future results.
4 Aug 2025, 21:42 UTC
Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone
DJ
Read
4 Aug 2025, 21:21 UTC
Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update
DJ
Read
4 Aug 2025, 20:45 UTC
Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb
DJ
Read
4 Aug 2025, 19:15 UTC
TransMedics Group Shares Rise on FDA Approval for Clinical Trial
DJ
Read
4 Aug 2025, 23:41 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Read
4 Aug 2025, 23:41 UTC
Nikkei May Rise on Fed Stimulus Hopes
DJ
Read
4 Aug 2025, 23:28 UTC
Global Equities Roundup: Market Talk
DJ
Read
4 Aug 2025, 23:28 UTC
Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk
DJ
Read
4 Aug 2025, 21:30 UTC
Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com
DJ
Read
4 Aug 2025, 21:21 UTC
Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com
DJ
Read
4 Aug 2025, 21:18 UTC
Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com
DJ
Read
4 Aug 2025, 20:25 UTC
India Hits Back Over Russian Oil Purchases -- Market Talk
DJ
Read
4 Aug 2025, 20:25 UTC
Transocean 2Q Loss $938M >RIG
DJ
Read
4 Aug 2025, 20:25 UTC
Transocean 2Q Loss/Shr $1.06 >RIG
DJ
Read
4 Aug 2025, 20:18 UTC
Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com
DJ
Read
4 Aug 2025, 20:15 UTC
Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX
DJ
Read
4 Aug 2025, 20:14 UTC
Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX
DJ
Read
4 Aug 2025, 20:14 UTC
Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX
DJ
Read
4 Aug 2025, 20:14 UTC
Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX
DJ
Read
4 Aug 2025, 20:13 UTC
Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX
DJ
Read
4 Aug 2025, 20:09 UTC
Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM
DJ
Read
4 Aug 2025, 20:06 UTC
Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com
DJ
Read
4 Aug 2025, 20:01 UTC
Vertex Pharmaceuticals 2Q Net $1.03B >VRTX
DJ
Read
4 Aug 2025, 20:01 UTC
Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX
DJ
Read
4 Aug 2025, 20:01 UTC
Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX
DJ
Read
4 Aug 2025, 20:01 UTC
Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX
DJ
Read
4 Aug 2025, 19:41 UTC
U.S. Natural Gas Futures Settle Lower -- Market Talk
DJ
Read
4 Aug 2025, 19:28 UTC
U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk
DJ
Read
4 Aug 2025, 19:07 UTC
Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk
DJ
Read
4 Aug 2025, 18:27 UTC
Gold Climbs on Rate Cut Speculation -- Market Talk
DJ
Read
Price change
By TipRanks
0 ratings
0
Buy
0
Hold
0
Sell
Based on 0 analysts giving stock ratings to Yiren Digital Ltd ADR - Dist in the past 3 months.
By Trading Central
Short Term
Bearish Evidence
Recent bearish events outweigh bullish events.
Intermediate Term
Weak Bullish Evidence
Recent bullish events outweigh bearish events.
Long Term
Bullish Evidence
Recent bullish events outweigh bearish events.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$